(Q68200704)
Statements
Phase II study of the therapeutic efficacy and safety of the new antimycotic sertaconazole in the treatment of superficial mycoses caused by Candida albicans (English)
Márquez M
P. Umbert
J. Nasarre
A. Bello
E. Herrero
P. Roset
M. Márquez
J. Torres